Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cysteine engineered antibodies and conjugates

Cysteine engineered antibodies and conjugates

US Patent 7521541 · Granted Apr 21, 2009

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Activatable antibodies that bind epidermal growth factor receptor and methods of2025
Anti-HER2 antibodies and immunoconjugates2025
Method of using an anti-epidermal growth factor receptor (EGFR) activatable anti2024
Compositions and methods for conjugating activatable antibodies2024
Activatable antibodies that bind epidermal growth factor receptor and methods th2024
Cysteine engineered antibodies and conjugates2024
Humanized anti-CD79B antibodies and immunoconjugates and methods of use2024
Anti-IL1-RAP antibodies2022
IL-22 Fc fusion proteins2022
Method of treating or delaying progression of an epidermal growth factor recepto2021
Multispecific antibodies, multispecific activatable antibodies and methods of us2021
Methods of treating acute pancreatitis using IL-22 fc fusion proteins2021